NCT00171353View on ClinicalTrials.gov

A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure

PHASE4CompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Hypertension
Interventions
DRUG

valsartan

Trial Locations (1)

Unknown

Novartis Pharmaceuticals, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00171353 - A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure | Biotech Hunter | Biotech Hunter